Neuropeptides of the vasoactive intestinal peptide/helodermin/pituitary adenylate cyclase activating peptide family elevate plasma cAMP in mice: comparison with a range of other regulatory peptides

This publication has 20 references indexed in Scilit:

• Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
  Trends in Pharmacological Sciences, 1990
• Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells
  Biochemical and Biophysical Research Communications, 1989
• Skeletal contribution of cyclic adenosine monophosphate in response to parathyroid hormone and calcitonin in vivo in the rat
  Journal of Bone and Mineral Research, 1988
• Mechanism of galanin-inhibited insulin release. Occurrence of a pertussis-toxin-sensitive inhibition of adenylate cyclase
  European Journal of Biochemistry, 1988
• Cyclic AMP and cyclic GMP phosphodiesterases: Target for drug development
  Drug Development Research, 1988
• Neuropeptide Y is a potent inhibitor of cyclic AMP accumulation in feline cerebral blood vessels
  Acta Physiologica Scandinavica, 1985
• Plasma cyclic AMP response to calcitonin: A potential clinical marker of bone turnover
  Bone, 1985
• Somatostatin analogs: Correlation of receptor affinity with inhibition of cyclic AMP formation in pancreatic acinar cells
  Peptides, 1985
• INFLUENCE OF SOMATOSTATIN ON PLASMA CYCLIC AMP AND METABOLIC SUBSTRATE RESPONSES TO I.V. ADRENALINE AND GLUCAGON IN HUMANS
  Clinical Endocrinology, 1981
• Some Aspects of the Biological Role of Adenosine 3',5'-monophosphate (Cyclic AMP)
  Circulation, 1968